Skip to content
On this page:OverviewPublicationsResearchersInstitutionsOpen access
PICO Portalanswers from OpenAlex

Verizon (United States)

InstitutionResearch output, impact & collaborations

Verizon (United States) is a institution indexed in PICO Portal from OpenAlex.

What is known about Verizon (United States)?

PICO Portalrecord summary

Verizon (United States) is a research organisation in New York, US. OpenAlex records 3,558 works and 101,264 citations for it. 927 researchers list it as their most recent affiliation.

How many works does Verizon (United States) have?

PICO Portalindexed works

Verizon (United States) has 3,558 works in the PICO Portal index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Verizon (United States) have?

PICO Portalcitation count

Verizon (United States) has 101,264 citations in the OpenAlex counts PICO Portal stores.

How many researchers are at Verizon (United States)?

PICO Portalresearcher count

Verizon (United States) has 927 researchers in the PICO Portal index.

What is the average h-index at Verizon (United States)?

PICO Portalavg h-index

Verizon (United States) has an average h-index of 71.5 in OpenAlex.

What is the ROR of Verizon (United States)?

PICO Portalror

The ROR for Verizon (United States) is on the source record.

What is the OpenAlex record for Verizon (United States)?

PICO Portalopenalex

The OpenAlex for Verizon (United States) is on the source record.

What is the Wikidata of Verizon (United States)?

PICO Portalwikidata

The Wikidata for Verizon (United States) is on the source record.

Who are the most-cited researchers behind Verizon (United States)?

PICO Portaltop researchers by citations
1
Massimo Aglietta · CAR-T cell therapy research
772 works24,814 citations
2
Tingbo Liang · Pancreatic and Hepatic Oncology Research
495 works18,017 citations

What are the most-cited papers on Verizon (United States)?

PICO Portalmost cited works
Durable Clinical Benefit With Nivolumab Plus Ipilimumab in DNA Mismatch Repair–Deficient/Microsatellite Instability–High Metastatic Colorectal Cancer
Michael J. Overman, Sara Lonardi, Ka Yeung Mark Wong, Heinz‐Josef Lenz, Fabio Gelsomino, Massimo Aglietta, Michael A. Morse, Eric Van Cutsem, Ray McDermott, Andrew Hill, Michael B. Sawyer, Alain Hendlisz, Bart Neyns, Magali Svrcek, Rebecca A. Moss, Jean-Marie Ledeine, Z. Alexander Cao, Shital Kamble, Scott Kopetz, Thierry André
Journal of Clinical Oncology. 20182,094 CitationsOPEN ACCESS
Durvalumab as third-line or later treatment for advanced non-small-cell lung cancer (ATLANTIC): an open-label, single-arm, phase 2 study
Marina Chiara Garassino, Byoung Chul Cho, Joo-Hang Kim, Julien Mazières, Johan Vansteenkiste, H. Léna, Jesus Corral Jaime, Jhanelle E Gray, John D. Powderly, C. Chouaïd, Paolo Bidoli, Paul Wheatley‐Price, Keunchil Park, Ross A. Soo, Yifan Huang, Catherine Wadsworth, Phillip A. Dennis, Naiyer A. Rizvi, Luis Paz-Ares Rodríguez, Silvia Novello, Sandrine Hiret, Peter Schmid, Eckart Laack, Raffaele Califano, Makoto Maemondo, Sang‐We Kim, Jamie E. Chaft, David Vicente Baz, Thierry Berghmans, Dong‐Wan Kim, Veerle Surmont, Martin Reck, Ji‐Youn Han, Esther Holgado Martin, Cristóbal Belda-Iniesta, Yuichiro Oe, Antonio Chella, Akhil Chopra, G. Robinet, Héctor Soto Parrà, Michael J. Thomas, Parneet Cheema, Nobuyuki Katakami, Wu‐Chou Su, Young‐Chul Kim, Juergen Wolf, Jong-Seok Lee, Hideo Saka, Michele Stanislaw Milella, Inmaculada Ramos García, Anne Sibille, Takashi Yokoi, Eun Joo Kang, Shinji Atagi, E. Spaeth-Schwalbe, Makoto Nishio, Fumio Imamura, Nashat Gabrail, Rémi Veillon, Sofie Derijcke, Tadashi Maeda, Dylan M. Zylla, Kendra Kubiak, Armando Santoro, Ma. Noemi Uy, Sarayut Lucien Geater, Antoîne Italiano, Dariusz M. Kowalski, Fabrice Barlési, Yuh‐Min Chen, David R. Spigel, Busyamas Chewaskulyong, Ramón García Gómez, Rosa Álvarez, Chih-Hsin Yang, Te‐Chun Hsia, Fabrice Denis, Hiroshi Sakai, Mark Vincent, Kōichi Goto, Joaquim Bosch‐Barrera, Glen J. Weiss, Jean-Luc Canon, Christian W. Scholz, Massimo Aglietta, Hirotsugu Kemmotsu, Koichi Azuma, Penelope A. Bradbury, Ronald Feld, Abraham Chachoua, Jacek Jassem, Rosalyn A. Juergens, Ramon Palmero Sanchez, Albert Malcolm, Nandagopal Vrindavanam, Kaoru Kubota, Cornelius F. Waller, David Waterhouse, Bruno Coudert, Z. Mark
The Lancet Oncology. 2018578 CitationsOPEN ACCESS

How much of the research on Verizon (United States) is open access?

PICO Portalopen access share
100%OPEN ACCESS
Gold
0%
Green
100%
Hybrid
0%
Bronze
0%
Closed
0%

Related on PICO Portal

470M+ articles · 14-day free trial